About us
Ascentia is a biotechnology company dedicated to identifying and developing small molecules that modulate key pathological processes involved in diseases driven by inflammation, fibrosis, or neoplastic mechanisms. In our projects, we focus on exploration of the therapeutic potential of undercharacterized transmembrane receptors.
We create
unique technologies
Based on the team's extensive experience and the latest knowledge in validating potential biological targets, designing chemical compounds with specific biological properties, and their synthesis, we develop research projects that span the entire process—from selecting a therapeutic target to discovering and optimizing molecules that interact with it, and ultimately verifying their effectiveness in animal models.
Taking on difficult challenges, we believe that the unique technologies we create will result in the discovery of new, effective drugs that will give patients a chance to overcome the disease.
